Chemokine receptor 5 (CCR5) delta 32 polymorphism in lupus nephritis: A large case-control study and meta-analysis
Chemokine receptor 5 (CCR5) delta 32 polymorphism in lupus nephritis: A large case-control study and meta-analysis
复制标题
DOI:
10.3109/08916934.2014.906581
复制
发表时间:
2014-09-01
期刊:
影响因子:
3.5
通讯作者:
Zhang, Hong
中科院分区:
文献类型:
--
作者:
Cheng, Fa-Juan;Zhou, Xu-Jie;Zhang, Hong
Objectives: Recent animal experiments showed that CCR5-deficient lupus mice (CCR5(-/-)) were closely associated with aggravated lupus nephritis. CCR5 Delta 32 variation, a nonsynonymous mutation of CCR5, resulted in altered CCR5 function. However, the CCR5 Delta 32 mutation in human lupus nephritis has been rarely reported in the literature. Methods: A large case-control study that included 2010 samples from a Chinese population was conducted, followed by a meta-analysis combining the current and previously published studies to explore the effect of CCR5 Delta 32 on lupus nephritis susceptibility. Results: Four CCR5 Delta 32 heterozygote carriers were detected in lupus nephritis patients only. We detected no CCR5 Delta 32 homozygotes in our study population. In the meta-analysis, including 1,092 cases and 2,229 controls, we found great heterogeneity between studies (p < 0.001, I-2 = 89.6%). Furthermore, stratified and sensitivity analyses suggested that ethnicity and CCR5 Delta 32 allele frequency were the main origin of heterogeneity. In the subgroups without obvious heterogeneity, we observed a positive correlation between CCR5 Delta 32 and lupus nephritis risk (p < 0.05). Conclusions: Our study confirmed that the CCR5 Delta 32 mutation is a very rare variation found in the Chinese population with Han ethnicity. However, CCR5 Delta 32 might play a role in lupus nephritis susceptibility. Future replications and functional studies are needed.